Nordson Corporation (NDSN) - Q1 2026 Filing Summary
Business Context and Reporting Period
This summary covers the Quarterly Report on Form 10-Q for Nordson Corporation for the three-month period ended January 31, 2026. Nordson is a global precision technology company manufacturing products for dispensing, applying, and controlling fluids, adhesives, and coatings, as well as medical devices. The company operates through three segments: Industrial Precision Solutions (IPS), Medical and Fluid Solutions (MFS), and Advanced Technology Solutions (ATS).
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Sales | $669.5 million | $615.4 million |
| Gross Margin | 54.7% | 54.6% |
| Operating Profit | $166.4 million | $140.9 million |
| Net Income | $133.4 million | $94.7 million |
| Diluted EPS | $2.38 | $1.65 |
| Operating Cash Flow | $140.4 million | $159.1 million |
| Cash & Equivalents | $120.4 million | $130.4 million |
| Total Debt (Current + Long-term) | $1,997.5 million | $2,000.0 million |
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 8.8% year-over-year, driven by a 6.5% organic increase and 3.7% currency impact. The Advanced Technology Solutions (ATS) segment saw the strongest growth at 23.1%, while Medical and Fluid Solutions (MFS) declined slightly by 0.2%.
- Profitability Surge: Net income rose 40.9% to $133.4 million. This was significantly aided by a one-time unrealized gain of $22.2 million on a minority investment included in "Other income - net."
- Segment Performance:
- IPS: Sales up 8.8%; EBITDA margin decreased 380 basis points due to mix.
- MFS: Sales flat; EBITDA margin improved 310 basis points following a divestiture.
- ATS: Sales up 23.1%; EBITDA margin improved 300 basis points.
- Capital Allocation: The company repurchased $86.0 million of treasury shares and paid $45.8 million in dividends. A new $1.2 billion revolving credit facility was established in January 2026, replacing prior term loans.
Outlook, Risks, and Unusual Items
- Unusual Items: The "Other income - net" line item includes a $22.2 million unrealized gain on a minority interest investment that became publicly listed in December 2025. This is a non-recurring item that significantly boosted net income.
- Tax Legislation: The "One Big Beautiful Bill Act" (OBBBA) signed in July 2025 did not materially impact the Q1 2026 results, though the company is assessing its impact for the full fiscal year.
- Liquidity: Management states liquidity is strong with $120.4 million in cash and $945.4 million in available borrowing capacity. The company remains in compliance with all debt covenants.
- Risks: Key risks include global economic conditions, currency exchange rate volatility, trade policy changes (tariffs), and geopolitical instability in Europe and the Middle East.
Investor Verification Checklist
- Quality of Earnings: Verify the sustainability of net income growth by excluding the $22.2 million unrealized investment gain from "Other income."
- Working Capital Trends: Investigate the $42.1 million decrease in cash provided by changes in operating assets/liabilities, specifically the slowdown in accounts receivable collections.
- Debt Structure: Review the terms of the new $1.2 billion revolving credit facility and the weighted average interest rate of 4.69% on outstanding borrowings.
- Segment Mix: Monitor the continued recovery in the ATS segment and the impact of the MFS divestiture on future organic growth rates.
- Share Count: Confirm the impact of the $86 million share repurchase program on future earnings per share accretion.